NXGL
NEXGEL, INC.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$4.01
−10.49%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$4.28
From 52W high−91.92%
Volume43814.00
Market cap$1.95M
P/E (TTM)—
P/S (TTM)0.2x
Div yield—
Key dataNov 4, 2026
Open
$4.28
From 52W high
−91.92%
Volume
43814.00
Market cap
$1.95M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−4.5x
P/E (TTM)
—
RSI (14)
46.9
MomentumView details →
1D Return
−10.49%
YTD Return
−86.93%
SummaryUpdated Jun 1, 2026
NEXGEL, Inc. (NASDAQ:NXGL) is a specialty hydrogel manufacturer founded in 1997 and based in Langhorne, Pennsylvania. Originally known as AquaMed Technologies, Inc., the company changed its name to NEXGEL in November 2019 and went public in December 2021. The company specializes in manufacturing high water content, electron beam cross-linked aqueous polymer hydrogels that serve multiple industries including wound care, medical diagnostics, transdermal drug delivery, and cosmetics. Over the past few years, NEXGEL has transformed from a primarily contract manufacturing business into a diversified company with both manufacturing services and branded consumer products.
Similar companies
Latest newsMore news →
NEXGEL said NASDAQ, INC. notified it that it had regained compliance with the minimum bid price requirement and that the matter was closed; its common stock will remain listed on the NASDAQ, INC. Capital Market.8d agoNEXGEL, Inc. announced that it will host its investor update call on September 24, 2026, at 4:15 p.m. Eastern Time, rescheduled from on or around September 15, 2026.49d agoNexGel, Inc. appointed Kevin Harris as Chair of the Special Committee for Strategic Review and Value Creation, effective August 20, 2026.76d ago